Unlock Full Company Report

Access verified contacts, investors & buying signals.

Get Access
Recently Funded|Amount: USD N/A|Industry: Medical Equipment Manufacturing

Aspivix Secures Key Funding to Revolutionize Women’s Health with Next-Gen Gynecology Devices

Aspivix

Aspivix Logo
N/A
2-10 employees employees (Est.)
Visit Website
View Full Report

Includes contacts, investors & buying signals

Aspivix, a Swiss medical device innovator dedicated to transforming women’s health, is excited to announce its latest funding round, securing an undisclosed amount of capital to accelerate the development and global rollout of its groundbreaking technologies. At the heart of this announcement is Carevix™, the world’s first suction cervical stabilizer that is setting a new standard in gynecological care. Clinically proven to reduce pain by up to 73% and bleeding by up to 83% during transcervical procedures such as IUD insertions, hysteroscopies, cervical biopsies, and fertility treatments, Carevix™ marks a transformative shift away from the century-old single-tooth tenaculum that has long dominated the field without consideration for patient comfort. This new infusion of investment will be strategically deployed to scale research and development initiatives, enhance production capabilities, and expand market penetration across both the US, where Carevix™ achieved FDA clearance in 2023, and European markets with its CE-Marked approval. With more than 120 million women worldwide still subjected to outdated and painful procedures, Aspivix is steadfast in its commitment to modernizing gynecology. The funds will also support further clinical trials and post-market studies to solidify Carevix™’s standing as a superior alternative to conventional devices, ensuring that women globally receive care that truly respects their anatomical needs and comfort. Aspivix’s vision is clear – every woman deserves a better, less painful experience during essential gynecologic procedures. This new funding round is not just an investment in technology, but an investment in a future where better, modern healthcare is accessible to every woman.
March 13, 2025

Buying Signals & Intent

Our AI suggests Aspivix may be interested in solutions related to:

  • Medical Device Manufacturing
  • Clinical Trials
  • Healthcare Technology
  • Women’s Health Solutions
  • Pain Management Solutions

Sell these products?

Unlock full report to find contacts.

Get Access Now

Investors

Unlock Investor Data

See who invested in Aspivix and potentially find related investment contacts.

Unlock Premium Access

Key Decision Makers

Unlock Verified Contacts

Get direct email addresses and phone numbers for key decision makers at Aspivix.

Unlock Contacts Now